Clinical trial
Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST): a Prospective, Random, Double Blinded and Multi-center Study
NCT05193071 is registered in ClinicalTrials.gov with General Hospital of Shenyang Military Region as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST): a Prospective, Random, Double Blinded and Multi-center Study
- Lead sponsor
- General Hospital of Shenyang Military Region
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 8, 2022
- Completion date
- October 25, 2024
- Enrollment
- 1,022 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.